A Shift in Molecular Drivers of Papillary Thyroid Carcinoma Following the 2017 World Health Organization Classification: Characterization of 554 Consecutive Tumors With Emphasis on BRAF-Negative Cases
Author:
Funder
National Science and Technology Council
Taipei Veterans General Hospital
Publisher
Elsevier BV
Subject
Pathology and Forensic Medicine
Reference41 articles.
1. Trends in thyroid cancer burden in Taiwan over two decades;Cheng;Cancer Causes Control,2023
2. WHO Classification of Tumours of Endocrine Organs,2017
3. Integrated genomic characterization of papillary thyroid carcinoma;Cell,2014
4. Genetic landscape of papillary thyroid carcinoma in the Chinese population;Liang;J Pathol,2018
5. Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study;Subbiah;Ann Oncol,2022
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A comparison of the histopathologic features of thyroid carcinomas with NTRK fusions to those with other malignant fusions;Human Pathology;2024-07
2. A computational approach to assessing the prognostic implications of BRAF and RAS mutations in patients with papillary thyroid carcinoma;Endocrine;2024-06-17
3. Multifocal Papillary Thyroid Carcinomas With Discordant Molecular Drivers;American Journal of Surgical Pathology;2024-05-31
4. Difficulties of Preoperative Diagnosis of Cribriform Morular Thyroid Carcinoma;Case Reports in Endocrinology;2024-05-28
5. Clinicopathologic Features and Cytologic Correlation of ALK-Rearranged Papillary Thyroid Carcinoma: A Series of Eight Cases;Endocrine Pathology;2024-04-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3